EODData

MEMBERSHIP REGISTER LOG IN

FRA, AX9: Akebia Therapeutics Inc

31 Mar 2026
LAST:

1.141

CHANGE:
 0.05		OPEN:
1.141		HIGH:
1.141		ASK:
0.000		VOLUME:
0
CHG(%):
4.29		PREV:
1.189		LOW:
1.141		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Mar 261.1411.1411.1411.1410
30 Mar 261.1381.1381.1381.1380
27 Mar 261.1891.1891.1891.1890
26 Mar 261.1871.1871.1871.1871.0K
25 Mar 261.1501.1501.1501.1501.0K
24 Mar 261.1921.1921.1921.1921.0K
23 Mar 261.1961.1961.1961.1961.0K
20 Mar 261.2051.2051.2051.2051.0K
19 Mar 261.2471.2471.2471.2470
18 Mar 261.2741.2741.2741.2740

PROFILE

Name:Akebia Therapeutics Inc
About:Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090 for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Address:245 First Street, Cambridge, MA, United States, 02142
Website:https://www.akebia.com
ISIN:US00972D1054
LEI:549300CBQEHMKEEGNX42

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.16 
Forward P/E:-1.76 
PEG Ratio:0.04 
Price to Sales:1.62 
Price to Book:10.32 
Profit Margin:-0.07 
Operating Margin:0.08 
Return on Assets:0.05 
Return on Equity:1.41 
Revenue:190.98M 
EBITDA:27.36M 
Shares:265.14M 
Market Cap:302.53M 

TECHNICAL INDICATORS

MA5:1.172.6%
MA10:1.215.8%
MA20:1.161.3%
MA50:1.140.2%
MA100:1.2913.3%
MA200:2.0579.4%
RSI14:58.17
WPR14:-100.00 
MTM14:-0.02
ROC14:-0.02 
ATR:0.03 
Week High:1.204.8%
Week Low:1.140.3%
Month High:1.3013.6%
Month Low:0.9979.4%
Year High:3.56212.4%
Year Low:0.9717.9%
Volatility:96.35